Precision System Science Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 7707
  • 1d0.50%
  • 1w1.01%
  • 1m-0.99%
  • 1y-45.38%
ATH
  • ATH Price$2,948.00
  • ATH Date2020-06-19
  • % since ATH-93.18%
  • % to ATH1,366.67%
ATL
  • ATL Price$4.09
  • ATL Date2013-12-25
  • % from ATL4,814.31%
  • Last Low Price$189
  • Last Low Date2024-02-16
  • % From Last Low6.35%
IPO
  • IPO Price$1,000,000.00
  • % Current ROI USD-99.98%
  • ATH Price$2,948.00
  • % ROI ATH 7,207,647.73%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="7707"]

Key Data [addtoany]

Current price $201
Sector Healthcare
Industry Medical Devices
Today's High/Low $201/$199
Volume 10,300.00
Previous Close $200
52 Week High/Low $381/$180
Market Cap 5,526,280,192.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$201
[addtoany]

Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally.
The company manufactures and sells plastic consumables, which are used in automated systems/instruments, as well as reagents; and automated nucleic acid extraction and veterinary biochemical analysis systems.
It also offers geneLEAD, an instrument for molecular testing; and engages in the research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests. Precision System Science Co., Ltd. was founded in 1985 and is headquartered in Matsudo, Japan.

Annual Data | Millions of US $ except per share data 2019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
Cash on hand ------------------
Receivables $1,200.34$932.05$820$1,001$1,074$970$2,441$862$550$655$426$594$685$848$698$718$577$384
Inventory $1,411.51$1,192.14$1,449.50$1,151.86$1,347$1,087$1,030$786$764$778$627$553$658$649$608$431$290$191
Pre-Paid Expenses ------------------
Other Current Assets $241.78$186.79$316.91$260.80$664$435$607$160$170$172$116$93$185$118$99$81$88$60
Total Current Assets $4,699.04$4,369.82$5,035.86$5,054.65$4,884$5,595------------
Property, Plant, And Equipment $740$700$709$708$1,443$1,574$1,046$736$821$752$805$933$1,069$990$1,162$1,053$990$868
Long-Term Investments $56$55$55$53$73$57------------
Goodwill And Intangible Assets ----$21$27------------
Other Long-Term Assets $6$3$3$4$2$3$68$7$30$14$11$13$31$3$7$3$3$21
Total Long-Term Assets $805.56$759.11$768.76$765.76--------------
Total Assets $5,504.60$5,128.93$5,804.63$5,820.41$6,454$7,298$11,488$4,584$4,602$5,238$4,123$4,224$5,169$4,884$4,636$4,874$2,967$2,303
Total Current Liabilities $1,286.06$1,389.91$1,385.82$1,668.89$1,564$2,192$1,524$841$880$1,154$739$866$1,149$962$906$1,177$1,284$879
Long Term Debt $233.03$385.52$628.02$618.28$735$665$807$1,092$820$642$751$933$1,161$990$619$664$734$585
Other Non-Current Liabilities $9$62$40$102$122$112$57$2$2$5$7$1$2$2$3-$1$1
Total Long Term Liabilities $241.31$447.64$667.47$719.44--------------
Total Liabilities $1,527.38$1,837.54$2,053.29$2,388.33$2,421$2,974$3,247$1,970$1,740$1,868$1,564$1,800$2,314$1,956$1,528$1,841$2,023$1,465
Common Stock Net $3,689$3,401$3,401$2,972$2,217$2,217$2,217$2,217$2,217$2,217$2,041$2,041$2,041$2,041$2,024$2,024$875$862
Retained Earnings (Accumulated Deficit) $-1,248.99$-1,379.31$-921.69$-366$1,215$1,567$1,165$151$340$843--------
Comprehensive Income ------------------
Other Share Holders Equity $-61$-39$-38$-95$11$-16------------
Share Holder Equity $3,977.23$3,291.39$3,751.34$3,390.96$3,694$4,019$4,924$2,460$2,709$3,184$2,401$2,424$2,855$2,928$3,108$3,033$944$838
Total Liabilities And Share Holders Equity ------------------